Skip to main content
Fig. 4 | Clinical Epigenetics

Fig. 4

From: Different methylation signatures at diagnosis in patients with high-risk myelodysplastic syndromes and secondary acute myeloid leukemia predict azacitidine response and longer survival

Fig. 4

Methylation pattern at time of disease progression after initial response is not similar to methylation pattern from those patients that have never respond (non-responders). Heatmap showing the hierarchical clusterization of samples from patients in progression (n =12) in comparison with responder (n =21) and non-responder (n =16) patients at diagnosis based on DNA methylation of the sites identified in Fig. 2

Back to article page
\